DIFFICULTIES IN MORPHOLOGICAL DIAGNOSIS OF MELANOCYTIC LESIONS: A CASE REPORT
https://doi.org/10.21294/1814-4861-2021-20-3-144-150
Abstract
Introduction. Skin cancer is one of the most common malignancies, however melanoma accounts for only 1.8 % of all skin cancers. Melanoma is rare but aggressive tumor. Early detection and appropriate treatment of the tumor are critical and result in improved overall and recurrence-free survival rates. Histopathological reporting plays a critical role in guiding the surgical oncologist’s treatment plan for melanocytic lesions. The experience and knowledge of the pathomorphologist are decisive in the future fate of the patient.
Case description. We report a case of a 36-year-old female patient who presented with a pigmented lesion on the skin of the trunk. In the regional cancer center at her place of residence, she underwent surgical removal of this lesion with a surgical margin of about 1 cm. The histological diagnosis was reported as melanoma. Diagnosis of melanoma was also confirmed in another medical center that did not specialize in the treatment of patients with skin tumors, but the tumor thickness was changed to a smaller one. However, in the federal cancer center that specialized in the treatment of patients with skin melanoma, the diagnosis of melanoma was not confirmed. The patient was diagnosed with nevus. The paper discusses in detail the reasons for the erroneous diagnosis of a malignant neoplasm, indicating the stages of differential diagnosis.
Conclusion. This clinical case demonstrates that a reference analysis of borderline melanocytic lesions under conditions of specialized cancer centers with experienced pathologists is required. We have described objective difficulties in pathomorphological diagnosis, which can additionally be aggravated by the absence of important clinical and instrumental information, artifacts during excision biopsy, macroscopic examination, and orientation of tissue fragments in the embedding paraffin block.
About the Authors
A. S. ArtemyevaRussian Federation
MD PhD, Head of the Pathological Department, Head of the Scientific Laboratory of Tumor Morphology
68, Leningradskaya street, 197758, St. Petersburg, Russia
Yu. V. Semiletova
Russian Federation
MD, PhD, Oncologist of the Oncology Department of the University clinic
154, Fontanka River Embankment, 199034, Russia, St. Petersburg
References
1. Kaprin A.D., Starinskiy V.V., Petrova G.V. Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow, 2019. 250 p. (in Russian).
2. Nosov D.A., Alekseev B.Ya., Volkova M.I., Gladkov O.A., Popov A.M., Kharkevich G.Yu. Practical Recommendations from RUSSCO. Malignant Tumors: 2019; 3s2 (Vol. 9): 498–506. (in Russian).
3. WHO. Classification of skin tumours. IARC, Lyon, 2018.
4. Massi G., LeBoit P.E. Histological diagnosis of nevi and melanoma. SecondEdition. Springer, 2014. 752 p.
5. Koh S.S., Cassarino D.S. Immunohistochemical expression of p16 in melanocytic lesions: an updated review and meta-analysis. Arch Pathol Lab Med. 2018; 142(7): 815–828.
6. Uguen A., Talagas M., Costa S., Duigou S., Bouvier S., De Braekeleer M., Marcorelles P. A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma. Diagn Pathol. 2015 Oct 26; 10: 195. doi: 10.1186/s13000-015-0431-9.
7. Oba J., Nakahara T., Abe T., Hagihara A., Moroi Y., Furue M. Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma: an immunohistochemical study and analysis of prognostic value. J Dermatol Sci. 2011 May; 62(2): 116–23. doi: 10.1016/j.jdermsci.2011.02.011.
Review
For citations:
Artemyeva A.S., Semiletova Yu.V. DIFFICULTIES IN MORPHOLOGICAL DIAGNOSIS OF MELANOCYTIC LESIONS: A CASE REPORT. Siberian journal of oncology. 2021;20(3):144-150. (In Russ.) https://doi.org/10.21294/1814-4861-2021-20-3-144-150